Embedded Files
Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Haemorrhage (TRIDENT)
Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Haemorrhage (TRIDENT)
Authors | New England Journal of Medicine | 2026
A low-dose triple single pill reduced the risk of recurrent stroke in patients who had suffered a brain haemorrhage.
Efficacy and safety of a novel low-dose triple single pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for the treatment of hypertension
Efficacy and safety of a novel low-dose triple single pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for the treatment of hypertension
Authors | The Lancet| 2024
Evaluates a new low-dose three-drug combination pill against two-drug combinations for treating high blood pressure.
Efficacy and safety of a novel low-dose triple single pill combination of telmisartan, amlodipine and indapamide, compared with placebo for initial treatment of hypertension
Efficacy and safety of a novel low-dose triple single pill combination of telmisartan, amlodipine and indapamide, compared with placebo for initial treatment of hypertension
Authors | Journal of the American College of Cardiology | 2024
Assesses the effectiveness and safety of a triple blood pressure pill compared to a placebo for initial hypertension treatment.
The efficacy and safety of interventions to prevent type 2 diabetes among women with recent gestational diabetes mellitus: a living systematic review and meta-analysis.
The efficacy and safety of interventions to prevent type 2 diabetes among women with recent gestational diabetes mellitus: a living systematic review and meta-analysis.
Authors | Journal of Diabetes | 2024
A systematic review analyzing methods to prevent type 2 diabetes in women who recently had gestational diabetes.
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension
Authors | Global Heart | 2024
Explains the underlying clinical reasoning and potential benefits of using a low-dose three-drug pill for hypertension management.
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3)
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3)
Authors | The Lancet | 2023
Investigates a comprehensive care bundle, including blood pressure reduction, for patients with acute brain hemorrhage.
Efficacy and Safety of Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for the Initial Management of Hypertension
Efficacy and Safety of Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for the Initial Management of Hypertension
Authors | JAMA Cardiology | 2023
Compares multi-drug combination pills against standard or single-drug therapies for early-stage hypertension treatment.
Effects of low-dose triple combination therapy on time at target blood pressure: secondary analysis of the TRIUMPH randomised controlled trial
Effects of low-dose triple combination therapy on time at target blood pressure: secondary analysis of the TRIUMPH randomised controlled trial
Authors | JAMA Cardiology | 2022
Analyzes how a low-dose triple pill affects the duration patients are able to maintain their target blood pressure levels.
Cardiovascular polypills to improve essential medicines access: ready for prime time?
Cardiovascular polypills to improve essential medicines access: ready for prime time?
Authors | Nature Medicine | 2022
Discusses the viability and readiness of cardiovascular polypills to increase global access to essential heart medications.
Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan and Sri Lanka
Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan and Sri Lanka
Authors | Lancet Global Health | 2021
Evaluates the financial feasibility and health economic value of a rural hypertension management program across South Asia.
Page updated
Report abuse